Cannabis Stocks look right to favor for bounce into 2022; Bitcoin breaks out again

Technical Strategy Video (Recorded Monday, November 8th):

Cannabis Stocks look right to favor for bounce into 2022; Bitcoin breaks out again

Key Takeaways

  • Equity indices still showing no evidence of reversal; However, breadth has been flat lately and VIX higher by 14% over the last three trading sessions. Until evidence of Tech, Financials and Healthcare turn lower, it’s right to still favor additional gains
  • Cannabis names look ripe to bounce sharply in the next 3-6 months after stock price performance literally has “gone up in smoke” for most of 2021
  • Materials sector can be favored for outperformance, as relative strength has surged in the last week and the group came close to hitting all-time highs Monday
  • Bitcoin likely to show better relative strength into late November after Monday’s gains

Equal-weighted Value Line Geometric Composite just pushed back to new all-time highs a couple weeks ago, showing a bullish albeit less overbought picture as the SPX or NDX.

Cannabis Stocks look right to favor for bounce into 2022; Bitcoin breaks out again
Source: Trading View

Cannabis issues likely to start to gain momentum after sharp rally on Monday

This entire group has been very hard hit for most of the year, and even after Monday’s gains, remains down more than 55% off peaks made nine months ago in February.

Reasons for optimism now are Three-fold. First, downtrends have been exceeded going back since this Summer which followed some meaningful positive momentum divergence.

Second, DeMark indicators show the potential for exhaustion in the form of TD Combo and/or TD Sequential 13 countdown patterns to be confirmed possibly by end of week. (Daily were confirmed last week; Weekly require a 11/12 close over $14.15.) So confirmation of a trend reversal looks close

Third and perhaps most importantly, mean reversion typically kicks in during the month of November most years, where laggards tend to bounce into February, while leaders underperform. This looks to be a very poor underperforming group for most of this year, so this bounce gives me optimism technically. The MJ or MJ Alternative Harvest ETF, is shown below, holds 5% or greater positions in ACB, TLRY, CGC, OGI, CRON, and GRWG. It looks right to start bottom fishing given the three reasons stated above.

Cannabis Stocks look right to favor for bounce into 2022; Bitcoin breaks out again
Source: Trading View

Materials almost hit new all-time highs, and likely outperforms if/when the US Dollar starts to turn lower with more velocity

The chart below illustrates the Equal-weighted Materials ETF by Invesco, ticker RTM. This looks bullish after recent gains, but might stall out temporarily near former peaks. Consolidation should provide attractive buying opportunities and it looks right to buy dips, looking to press longs on gains back to new highs.

Cannabis Stocks look right to favor for bounce into 2022; Bitcoin breaks out again
Source: Optuma

Finally, Bitcoin broke out above the key $63.3k area that effectively breaks the triangle pattern from 10/20 nearly a month ago. This is constructive technically and should carry prices up to 72k initially and then 77.6k which are measured Extension targets based on the initial rally up from July. Momentum is not yet overbought on daily nor weekly timeframes.

Bitcoin now showing evidence that it might show better relative strength than Altcoins in the weeks to come based on a breakout in its Market-cap Dominance chart

Cycles in Bitcoin and Ethereum show upward progress into end of November before a peak in price that could persist into 2022. Thus, this breakout in BTCUSD might signal the start of a final push-up for Q4 2021 before the Crypto market shows more pronounced consolidation into next year. At present, this is premature, and strength in Bitcoin, Ethereum and many other Altcoins looks likely in the weeks to come.

Cannabis Stocks look right to favor for bounce into 2022; Bitcoin breaks out again
Source: Optuma
Disclosures (show)

This research is for the clients of FS Insight only. FSI Subscription entitles the subscriber to 1 user, research cannot be shared or redistributed. For additional information, please contact your sales representative or FS Insight at fsinsight.com.

Conflicts of Interest

This research contains the views, opinions and recommendations of FS Insight. At the time of publication of this report, FS Insight does not know of, or have reason to know of any material conflicts of interest.

General Disclosures

FS Insight is an independent research company and is not a registered investment advisor and is not acting as a broker dealer under any federal or state securities laws.

FS Insight is a member of IRC Securities’ Research Prime Services Platform. IRC Securities is a FINRA registered broker-dealer that is focused on supporting the independent research industry. Certain personnel of FS Insight (i.e. Research Analysts) are registered representatives of IRC Securities, a FINRA member firm registered as a broker-dealer with the Securities and Exchange Commission and certain state securities regulators. As registered representatives and independent contractors of IRC Securities, such personnel may receive commissions paid to or shared with IRC Securities for transactions placed by FS Insight clients directly with IRC Securities or with securities firms that may share commissions with IRC Securities in accordance with applicable SEC and FINRA requirements. IRC Securities does not distribute the research of FS Insight, which is available to select institutional clients that have engaged FS Insight.

As registered representatives of IRC Securities our analysts must follow IRC Securities’ Written Supervisory Procedures. Notable compliance policies include (1) prohibition of insider trading or the facilitation thereof, (2) maintaining client confidentiality, (3) archival of electronic communications, and (4) appropriate use of electronic communications, amongst other compliance related policies.

FS Insight does not have the same conflicts that traditional sell-side research organizations have because FS Insight (1) does not conduct any investment banking activities, and (2) does not manage any investment funds.

This communication is issued by FS Insight and/or affiliates of FS Insight. This is not a personal recommendation, nor an offer to buy or sell nor a solicitation to buy or sell any securities, investment products or other financial instruments or services. This material is distributed for general informational and educational purposes only and is not intended to constitute legal, tax, accounting or investment advice.
The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.
Intended for recipient only and not for further distribution without the consent of FS Insight.

This research is for the clients of FS Insight only. Additional information is available upon request. Information has been obtained from sources believed to be reliable, but FS Insight does not warrant its completeness or accuracy except with respect to any disclosures relative to FS Insight and the analyst’s involvement (if any) with any of the subject companies of the research. All pricing is as of the market close for the securities discussed, unless otherwise stated. Opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. Past performance is not indicative of future results. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, risk tolerance, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies. The recipient of this report must make its own independent decision regarding any securities or financial instruments mentioned herein. Except in circumstances where FS Insight expressly agrees otherwise in writing, FS Insight is not acting as a municipal advisor and the opinions or views contained herein are not intended to be, and do not constitute, advice, including within the meaning of Section 15B of the Securities Exchange Act of 1934. All research reports are disseminated and available to all clients simultaneously through electronic publication to our internal client website, fsinsight.com. Not all research content is redistributed to our clients or made available to third-party aggregators or the media. Please contact your sales representative if you would like to receive any of our research publications.

Copyright © 2025 FS Insight LLC. All rights reserved. No part of this material may be reprinted, sold or redistributed without the prior written consent of FS Insight LLC.